PMID- 28494372 OWN - NLM STAT- MEDLINE DCOM- 20180813 LR - 20180813 IS - 1873-3557 (Electronic) IS - 1386-1425 (Linking) VI - 184 DP - 2017 Sep 5 TI - Separation and preconcentration of riboflavin from human plasma using polythionine coated magnetite/hydroxyapatite nanocomposite prior to analysis by surfactant-enhanced fluorimetry. PG - 109-118 LID - S1386-1425(17)30365-7 [pii] LID - 10.1016/j.saa.2017.04.087 [doi] AB - The exploration of novel adsorption properties of conductive polymers based on hybridization with biocompatible nanomaterials receives an increasing interest. In this regard, hydroxyapatite (HA) bioceramic is of critical importance mainly owing to its facile synthesis, high surface area, economic and low toxicity in biological environments. In this work, we first prepared and characterized a magnetite/hydroxyapatite (Fe(3)O(4)/HA) nanocomposite using the bio-waste chicken eggshell via an attractive green way that involved low cost and irrespective of toxicity. Then, polythionine as a novel class of conductive polymers was in situ coated on the synthesized magnetic bioceramic for the separation and preconcentration of riboflavin (vitamin B(2)) in human plasma before its fluorimetric determination. Considering the putative role of riboflavin in protecting against cancer and cardiovascular diseases, it is essential to evaluate this vitamin in biological fluids. The described method possesses a linear range of 0.75-262.5mugL(-1) (R(2)=0.9985) and a detection limit of 0.20mugL(-1) (signal-to-noise ratio of 3). The relative standard deviations (RSDs) for single-sorbent repeatability and sorbent-to-sorbent reproducibility were less than 4.0% and 7.6% (n=5), respectively. The respective enrichment factor and extraction recovery of the method found to be 35.7 and 98.4%. The analytical performance of method for riboflavin was characterized by good consistency of the results with those obtained by the enzyme-linked immunosorbent assay (ELISA) conventional method (p-value of <0.05). The optimized protocol intended for control determinations of riboflavin in human subjects and is addressed to clinical laboratories. CI - Copyright (c) 2017 Elsevier B.V. All rights reserved. FAU - Farzin, Leila AU - Farzin L AD - Radiation Application Research School, Nuclear Science and Technology Research Institute, P.O. Box 11365-3486, Tehran, Iran. Electronic address: lfarzin84@yahoo.com. FAU - Shamsipur, Mojtaba AU - Shamsipur M AD - Department of Chemistry, Razi University, P.O. Box 67149-67346, Kermanshah, Iran. LA - eng PT - Journal Article DEP - 20170502 PL - England TA - Spectrochim Acta A Mol Biomol Spectrosc JT - Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy JID - 9602533 RN - 0 (Magnetite Nanoparticles) RN - 0 (Phenothiazines) RN - 0 (Polymers) RN - 0 (Surface-Active Agents) RN - 91D9GV0Z28 (Durapatite) RN - TLM2976OFR (Riboflavin) RN - VTT2SAT5H0 (thionine) SB - IM MH - Adult MH - Durapatite/*chemistry MH - Humans MH - Limit of Detection MH - Linear Models MH - Magnetite Nanoparticles/*chemistry MH - Nanocomposites/chemistry MH - Phenothiazines/chemistry MH - Polymers/chemistry MH - Reproducibility of Results MH - Riboflavin/*blood/*isolation & purification MH - Spectrometry, Fluorescence/*methods MH - Surface-Active Agents/*chemistry OTO - NOTNLM OT - Fluorimetric determination OT - Hydroxyapatite OT - Polythionine OT - Riboflavin EDAT- 2017/05/12 06:00 MHDA- 2018/08/14 06:00 CRDT- 2017/05/12 06:00 PHST- 2017/01/18 00:00 [received] PHST- 2017/04/19 00:00 [revised] PHST- 2017/04/30 00:00 [accepted] PHST- 2017/05/12 06:00 [pubmed] PHST- 2018/08/14 06:00 [medline] PHST- 2017/05/12 06:00 [entrez] AID - S1386-1425(17)30365-7 [pii] AID - 10.1016/j.saa.2017.04.087 [doi] PST - ppublish SO - Spectrochim Acta A Mol Biomol Spectrosc. 2017 Sep 5;184:109-118. doi: 10.1016/j.saa.2017.04.087. Epub 2017 May 2.